name:-0.033211946487427
name:-0.023139953613281
name:-0.01458477973938
Gao; Xiaolei Patent Filings

Gao; Xiaolei

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gao; Xiaolei.The latest application filed is for "3-(1h-pyrazol-4-yl)pyridine allosteric modulators of the m4 muscarinic acetylcholine receptor".

Company Profile
18.28.40
  • Gao; Xiaolei - Bridgewater NJ
  • Gao; Xiaolei - Kenilworth NJ
  • Gao; Xiaolei - Scotch Plains NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,339,156 - Acton, III , et al. May 24, 2
2022-05-24
Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,319,298 - Bao , et al. May 3, 2
2022-05-03
6,5-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,230,556 - Gao , et al. January 25, 2
2022-01-25
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20210395224 - Acton, III; John J. ;   et al.
2021-12-23
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20210380580 - ACTON, III; John J. ;   et al.
2021-12-09
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,149,036 - Acton, III , et al. October 19, 2
2021-10-19
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 10,933,056 - Acton, III , et al. March 2, 2
2021-03-02
6,6-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 10,836,775 - Gao , et al. November 17, 2
2020-11-17
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20200207758 - ACTON, III; John J. ;   et al.
2020-07-02
6,5-fused Heteroaryl Piperidine Ether Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20200095261 - GAO; Xiaolei ;   et al.
2020-03-26
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20200069671 - Acton, III; John J. ;   et al.
2020-03-05
6,6-fused Heteroaryl Piperidine Ether Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20190315762 - GAO; Xiaolei ;   et al.
2019-10-17
Heteroaryl Piperidine Ether Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20190315708 - BAO; Jianming ;   et al.
2019-10-17
6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 10,351,564 - Gao , et al. July 16, 2
2019-07-16
6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 10,329,289 - Bao , et al.
2019-06-25
6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20190062331 - BAO; JIANMING ;   et al.
2019-02-28
Btk inhibitors
Grant 10,214,546 - Liu , et al. Feb
2019-02-26
Tertiary alcohol imidazopyrazine BTK inhibitors
Grant 10,208,047 - Liu , et al. Feb
2019-02-19
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20190000824 - Acton, III; John J. ;   et al.
2019-01-03
Benzamide imidazopyrazine Btk inhibitors
Grant 10,087,188 - Liu , et al. October 2, 2
2018-10-02
Substituted imidazo[1,5-a]pyrazines as Btk inhibitors
Grant 10,040,805 - Liu , et al. August 7, 2
2018-08-07
Azacarbazole Btk Inhibitors
App 20180141962 - LIU; JIAN ;   et al.
2018-05-24
Btk Inhibitors
App 20180118766 - LIU; JIAN ;   et al.
2018-05-03
Imidazopyrazine Analogs With 3-tertiary Carbon Substitutions As Btk Inhibitors
App 20180009828 - LIU; JIAN ;   et al.
2018-01-11
Biarylether Imidazopyrazine Btk Inhibitors
App 20170362243 - LIU; JIAN ;   et al.
2017-12-21
Benzamide Imidazopyrazine Btk Inhibitors
App 20170362242 - LIU; JIAN ;   et al.
2017-12-21
Tertiary Alcohol Imidazopyrazine Btk Inhibitors
App 20170342076 - LIU; JIAN ;   et al.
2017-11-30
BTK Inhibitors
Grant 9,718,828 - De Man , et al. August 1, 2
2017-08-01
6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20170183342 - BAO; JIANMING ;   et al.
2017-06-29
Btk Inhibitors
App 20170008899 - DE MAN; ADRIANUS PETRUS ANTONIUS ;   et al.
2017-01-12
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
Grant 9,481,682 - Kim , et al. November 1, 2
2016-11-01
Fused pyrazole derivatives as novel ERK inhibitors
Grant 9,242,981 - Shipps, Jr. , et al. January 26, 2
2016-01-26
Btk Inhibitors
App 20150353570 - KIM; RONALD M. ;   et al.
2015-12-10
Compounds that are ERK inhibitors
Grant 8,999,966 - Boga , et al. April 7, 2
2015-04-07
Heterocyclic compounds as ERK inhibitors
Grant 8,999,957 - Deng , et al. April 7, 2
2015-04-07
Btk Inhibitors
App 20140221333 - De Man; Adrianus Petrus Antonius ;   et al.
2014-08-07
Btk Inhibitors
App 20140206681 - KIM; RONALD M. ;   et al.
2014-07-24
Compounds that are ERK inhibitors
Grant 8,716,483 - Cooper , et al. May 6, 2
2014-05-06
Compounds that are ERK inhibitors
Grant 8,546,404 - Cooper , et al. October 1, 2
2013-10-01
Novel Compounds That Are Erk Inhibitors
App 20130237518 - Boga; Sobhana Babu ;   et al.
2013-09-12
Fused Pyrazole Derivatives As Novel Erk Inhibitors
App 20130172341 - Shipps, JR.; Gerald W. ;   et al.
2013-07-04
Novel Heterocyclic Compounds As Erk Inhbitors
App 20130096084 - Deng; Yongqi ;   et al.
2013-04-18
Novel Compounds That Are Erk Inhibitors
App 20110189192 - Cooper; Alan B. ;   et al.
2011-08-04
Heterocyclic Compounds And Use Thereof As Erk Inhibitors
App 20110038876 - Sun; Robert ;   et al.
2011-02-17
Novel compounds that are ERK inhibitors
App 20090118284 - Cooper; Alan B. ;   et al.
2009-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed